Freenome, Inc. Common stock

FRNMNASDAQUSD
12.38 USD
1.13 (10.10%)🟢PRE MARKET (AS OF 09:24 AM EDT)
🟢Market: OPEN

FRNM is currently priced at $12.38. The technical outlook is "Sell" based on moving average alignment, RSI, and MACD signals. Key drivers include a bullish Golden Cross on the moving averages.

Technical & fundamental data as of Jul 24, 2026.

Open?$11.25
High?$12.72
Low?$11.25
Prev. Close?$11.24
Volume?49.2K
Avg. Volume?N/A
VWAP?$12.44
Bid / Ask
Bid?$9.08 × 100
Ask?$12.98 × 100
Spread?$3.90
Midpoint?$11.03
Valuation & Ratios
Market Cap?1.2B
Shares Out?107.0M
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
Freenome Inc is a development-stage, early cancer detection company developing blood-based screening tests leveraging a proprietary artificial intelligence/machine learning multiomics technology platform to transform multi-cancer and ultimately multi-disease detection. It is developing a range of blood-based cancer screening tests.
Employees
N/A
Market Cap
1.2B
Industry
SERVICES-MEDICAL LABORATORIES
Listed
2026-07-21
Address
51 ASTOR PLACE, 10TH FLOOR
NEW YORK, NY 10003
Phone: 212-284-2300
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-1/3)
Medium-Term (Wave)? Bearish(-2/3)
Short-Term (Ripple)? Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental Outlook
Loading...
Short Interest
Loading...